Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
fda
immunotherapy
3
×
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
chronic kidney disease
clinical trials
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
medicare
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acquisition
acute myeloid leukemia
What
days
3
×
abbvie’s
ahead
airport
annual
apocalypse
arrival
beds
bio
biofourmis
biotech
bucks
cancer
celebrate
celgene
chance
companies
corner
day
fallout
forward
gone
hasn’t
holiday
home
industry
ipo
ipos
j.p
jpm
labor
life
looking
market
momentum
new
notes
people
pharma
price
Language
unset
Current search:
days
×
national
×
immunotherapy
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More